Author:
Schiavina Riccardo,Bianchi Lorenzo,Borghesi Marco,Sabbatini Roberto,Brunocilla Eugenio
Reference13 articles.
1. Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials;Van Soest;BMC Med,2015
2. Diagnosis of bone metastases: a meta-analysis comparing (1)(8)FDG PET, CT, MRI and bone scintigraphy;Yang;Eur Radiol,2011
3. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?;Lecouvet;Eur Urol,2012
4. The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?;Schiavina;Curr Radiopharm,2013
5. Padhani A.R., Lecouvet F.E., Tunariu N., et al. Modern imaging techniques. including whole-body magnetic resonance imaging and positron emission tomography/computed tomography scans with a variety of tracers, have the potential to address the unmet need for robust imaging that allows tumour detection and therapy evaluations in advanced prostate cancer. EU Focus (in press).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献